|
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
91 |
Global |
$2,500.00 |
|
|
Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
31 |
Global |
$2,500.00 |
|
|
Wounds Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
241 |
Global |
$2,500.00 |
|
|
Peripheral Neuropathic Pain Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
104 |
Global |
$2,500.00 |
|
|
Wrinkles Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
109 |
Global |
$2,500.00 |
|
|
Ocular Pain Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
52 |
Global |
$2,500.00 |
|
|
Cellulite Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
37 |
Global |
$2,500.00 |
|
|
Myalgia Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
63 |
Global |
$2,500.00 |
|
|
Sciatic Pain Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
42 |
Global |
$2,500.00 |
|
|
Multiple Sclerosis Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
1031 |
Global |
$2,500.00 |
|
|
Tic Disorder Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
75 |
Global |
$2,500.00 |
|
|
Spinal Muscular Atrophy (SMA) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
73 |
Global |
$2,500.00 |
|
|
Trichotillomania Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
29 |
Global |
$2,500.00 |
|
|
Spina Bifida Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
39 |
Global |
$2,500.00 |
|
|
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
39 |
Global |
$2,500.00 |
|
|
Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
45 |
Global |
$2,500.00 |
|
|
Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
177 |
Global |
$2,500.00 |
|
|
Traumatic Spinal Cord Injury Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
46 |
Global |
$2,500.00 |
|
|
Periventricular Leukomalacia Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
36 |
Global |
$2,500.00 |
|
|
Acne Vulgaris Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
357 |
Global |
$2,500.00 |
|
|
Neuromyelitis Optica (Devic’s Syndrome) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
63 |
Global |
$2,500.00 |
|
|
Xerosis (Dry Skin) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
44 |
Global |
$2,500.00 |
|
|
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
159 |
Global |
$2,500.00 |
|
|
Status Epilepticus Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
62 |
Global |
$2,500.00 |
|
|
Muscle Spasticity Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
189 |
Global |
$2,500.00 |
|
|
Tick Borne Encephalitis Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
50 |
Global |
$2,500.00 |
|
|
Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
52 |
Global |
$2,500.00 |
|
|
Spinal Stenosis Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
73 |
Global |
$2,500.00 |
|
|
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
27 |
Global |
$2,500.00 |
|
|
Spinal Cord Injury Global Clinical Trials Review, H2, 2016 |
Jul 27 2016 |
199 |
Global |
$2,500.00 |
|
